CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 86 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,181,417
+25.6%
51,534
-9.6%
0.00%
+100.0%
Q2 2023$940,408
+0.6%
57,029
+8.8%
0.00%0.0%
Q1 2023$935,208
-9.0%
52,422
+48.5%
0.00%
-50.0%
Q4 2022$1,028,111
+29.0%
35,306
+8.6%
0.00%
+100.0%
Q3 2022$797,000
+499.2%
32,520
+1.8%
0.00%
Q2 2022$133,000
-76.2%
31,946
-34.3%
0.00%
-100.0%
Q1 2022$560,000
+4.9%
48,651
-9.0%
0.00%0.0%
Q4 2021$534,000
-22.2%
53,489
+1.9%
0.00%0.0%
Q3 2021$686,000
-42.3%
52,492
-13.6%
0.00%0.0%
Q2 2021$1,189,000
-2.8%
60,739
+5.7%
0.00%
-50.0%
Q1 2021$1,223,000
-18.8%
57,485
+13.4%
0.00%0.0%
Q4 2020$1,507,000
+37.2%
50,6850.0%0.00%0.0%
Q3 2020$1,098,000
-2.8%
50,6850.0%0.00%0.0%
Q2 2020$1,130,000
+64.0%
50,685
+11.9%
0.00%
+100.0%
Q1 2020$689,000
-33.0%
45,288
+1.2%
0.00%
-50.0%
Q4 2019$1,028,000
+33.0%
44,766
+25.0%
0.00%0.0%
Q3 2019$773,000
-0.6%
35,799
+1.2%
0.00%0.0%
Q2 2019$778,000
+21.8%
35,372
+51.8%
0.00%
+100.0%
Q1 2019$639,000
+1.3%
23,306
-0.8%
0.00%0.0%
Q4 2018$631,000
-6.7%
23,491
+1.4%
0.00%0.0%
Q3 2018$676,000
+15.4%
23,158
+23.5%
0.00%0.0%
Q2 2018$586,000
+131.6%
18,758
+47.4%
0.00%0.0%
Q1 2018$253,000
-32.9%
12,730
-2.0%
0.00%0.0%
Q4 2017$377,00012,9860.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders